§ 13F · FUND PROFILE
venBio Partners LLC.
AUM · $519M (13F)Positions · 7Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$183M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 14, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | PHVS | PHARVARIS N V | 4.64M | $161M | 30.9% | ±0% |
| 2 | PBLS | PARABILIS MEDICINES INC | 5.27M | $144M | 27.8% | NEW |
| 3 | ALMS | ALUMIS INC | 4.53M | $127M | 24.5% | ±0% |
| 4 | ACHV | ACHIEVE LIFE SCIENCE INC | 5.91M | $39M | 7.4% | NEW |
| 5 | ALXO | ALX ONCOLOGY HLDGS INC | 12.88M | $27M | 5.1% | ±0% |
| 6 | HRMY | HARMONY BIOSCIENCES HLDGS IN | 472K | $17M | 3.3% | −3% |
| 7 | LYEL | LYELL IMMUNOPHARMA INC | 338K | $5M | 0.9% | ±0% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE VENBIO SIGNAL
AC read
venBio Partners LLC is a Other fund managing $519 million in assets. The fund runs a focused portfolio of just 7 positions.
Read the full dossier →